SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

NORRIS MEDICINES

BSE: 524414 28 Jun 2025
Services
₹ 18.8
Norris Medicines Ltd. specializes in Trading & Distributors within the Services sector.

NORRIS MEDICINES - Share Price & Details

Market Cap
₹18.0
High /Low
27.7 / 11.4
Stock P/E
NA
Book Value
₹-14.9
Dividend Yield
0.0
ROCE
-10.1
ROE
₹NA
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹-198.0
Debt
21.6
CMP / FCF
31.6
Debt to equity
₹NA
NP Ann
-1.24
High price all time
36.8
Piotroski score
₹4.0
Graham Number
NA
No. Eq. Shares
1.0
Net CF
₹0.40
Net profit
-1.24
Price to book value
NA
Interest Coverage
₹-1.68
Low price all time
2.45
Industry PE
34.7
Reserves
₹-24.8
Free Cash Flow
₹0.28

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Alna Trading & Exports Ltd.,NANANANA0
Oseaspre Consultants Ltd.,NANANANA0
NORRIS MEDICINES LTD.NANANANA18.0
INTER STATE OIL CARRIER LTD.NANANANA1815.8
Cargosol Logistics LimitedNANANANA17.6294.0

Peer Comparison Chart


About NORRIS MEDICINES

Norris Medicines Ltd., with Security Code 524414, is a leading player in the Trading & Distributors industry, categorized under the Services sector, offering Equity instruments.


Latest News

Norris Medicines Experiences Shift in Market Sentiment Amid Financial Challenges

(11 Jun 2025)
Norris Medicines, a microcap in the Trading & Distributors sector, has experienced a shift in its technical indicators, moving towards a...
Read more →

How has been the historical performance of the Norris Medicines?

(11 Jun 2025)
Norris Medicines has experienced a significant decline in net sales and profitability, with net sales dropping from Rs 16.27 crore in March 2019 to Rs 5.82...
Read more →

Norris Medicines Ltd Faces Increased Selling Pressure Amidst Consecutive Losses

(10 Jun 2025)
Norris Medicines Ltd is experiencing notable selling pressure, continuing a trend of losses with a 2.81% decline today. Despite a strong monthly performance...
Read more →

Norris Medicines Faces Mixed Technical Trends Amid Strong Yearly Performance and Fundamental Challenges

(05 Jun 2025)
Norris Medicines, a microcap in the Trading & Distributors sector, has experienced a recent evaluation adjustment reflecting shifts in...
Read more →

Norris Medicines Ltd Sees Strong Buying Activity Amid Notable Price Gains

(05 Jun 2025)
Norris Medicines Ltd is experiencing notable buying activity, with a significant increase in its stock price today, outperforming the Sensex...
Read more →

Norris Medicines Faces Intense Selling Pressure Amid Consecutive Losses and Market Shift

(04 Jun 2025)
Norris Medicines Ltd is experiencing notable selling pressure, marked by consecutive losses and a significant decline in stock value.
Read more →